https://www.marketscreener.com/quote/stock/GENE-BIOTHERAPEUTICS-INC-120789731/news/Cardium-Therapeutics-to-Announce-Interim-Results-of-Generx-Angiogenic-Gene-Therapy-Phase-3-Clinical-38691927/?utm_source=telegram&utm_medium=social&utm_campaign=share